APO Research
Talk to an analyst

APO RESEARCH · REPORT

BNCT Treatment

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global BNCT Treatment Market Outlook and Growth Opportunities 2026

4 March 2026197 pages

Choose your research edition.

Industry ResearchBNCT Treatment Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal BNCT Treatment Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal BNCT Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal BNCT Treatment Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal BNCT Treatment Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global BNCT Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for BNCT Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for BNCT Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for BNCT Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the BNCT Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the BNCT Treatment market include Neutron Therapeutics, Sumitomo Heavy Industries, International Particle Therapy Inc (IPT), RaySearch, Neuboron Medtech, TAE Life Sciences and Stella Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global BNCT Treatment market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of BNCT Treatment and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents BNCT Treatment revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global BNCT Treatment market.

BNCT Treatment Segment by Company

Neutron Therapeutics

Sumitomo Heavy Industries

International Particle Therapy Inc (IPT)

RaySearch

Neuboron Medtech

TAE Life Sciences

Stella Pharma

BNCT Treatment Segment by Type

Equipment

Solution

Drug

BNCT Treatment Segment by Application

Head and Neck Cancer

Brain Tumor

Others

BNCT Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global BNCT Treatment status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the BNCT Treatment key companies, revenue, market share, and recent developments.

3. To split the BNCT Treatment breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions BNCT Treatment market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify BNCT Treatment significant trends, drivers, influence factors in global and regions.

6. To analyze BNCT Treatment competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global BNCT Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of BNCT Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of BNCT Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global BNCT Treatment industry.

Chapter 3: Detailed analysis of BNCT Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of BNCT Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of BNCT Treatment in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. BNCT Treatment Industry Trends Table 2. BNCT Treatment Industry Drivers Table 3. BNCT Treatment Industry Opportunities and Challenges Table 4. BNCT Treatment Industry Restraints Table 5. Global BNCT Treatment Revenue by Company (US$ Million) & (2021-2026) Table 6. Global BNCT Treatment Revenue Share by Company (2021-2026) Table 7. Global BNCT Treatment Company Ranking, (2024-2026) & (US$ Million) Table 8. Global BNCT Treatment Key Company Manufacturing Base & Headquarters Table 9. Global BNCT Treatment Company, Product Type & Application Table 10. Global BNCT Treatment Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global BNCT Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Equipment Table 15. Significant Companies of Solution Table 16. Significant Companies of Drug Table 17. Global BNCT Treatment Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global BNCT Treatment Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global BNCT Treatment Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global BNCT Treatment Sales Value Share by Type (2021-2026) Table 21. Global BNCT Treatment Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Head and Neck Cancer Table 23. Significant Companies of Brain Tumor Table 24. Significant Companies of Others Table 25. Global BNCT Treatment Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global BNCT Treatment Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global BNCT Treatment Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global BNCT Treatment Sales Value Share by Application (2021-2026) Table 29. Global BNCT Treatment Sales Value Share by Application (2027-2032) Table 30. Global BNCT Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global BNCT Treatment Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global BNCT Treatment Sales Value Share by Region (2021-2026) Table 33. Global BNCT Treatment Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global BNCT Treatment Sales Value Share by Region (2027-2032) Table 35. Global BNCT Treatment Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global BNCT Treatment Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global BNCT Treatment Sales Value Market Share by Country (2021-2026) Table 38. Global BNCT Treatment Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global BNCT Treatment Sales Value Market Share by Country (2027-2032) Table 40. Neutron Therapeutics Company Information Table 41. Neutron Therapeutics Business Overview Table 42. Neutron Therapeutics BNCT Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Neutron Therapeutics BNCT Treatment Product Portfolio Table 44. Neutron Therapeutics Recent Development Table 45. Sumitomo Heavy Industries Company Information Table 46. Sumitomo Heavy Industries Business Overview Table 47. Sumitomo Heavy Industries BNCT Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Sumitomo Heavy Industries BNCT Treatment Product Portfolio Table 49. Sumitomo Heavy Industries Recent Development Table 50. International Particle Therapy Inc (IPT) Company Information Table 51. International Particle Therapy Inc (IPT) Business Overview Table 52. International Particle Therapy Inc (IPT) BNCT Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. International Particle Therapy Inc (IPT) BNCT Treatment Product Portfolio Table 54. International Particle Therapy Inc (IPT) Recent Development Table 55. RaySearch Company Information Table 56. RaySearch Business Overview Table 57. RaySearch BNCT Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. RaySearch BNCT Treatment Product Portfolio Table 59. RaySearch Recent Development Table 60. Neuboron Medtech Company Information Table 61. Neuboron Medtech Business Overview Table 62. Neuboron Medtech BNCT Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Neuboron Medtech BNCT Treatment Product Portfolio Table 64. Neuboron Medtech Recent Development Table 65. TAE Life Sciences Company Information Table 66. TAE Life Sciences Business Overview Table 67. TAE Life Sciences BNCT Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. TAE Life Sciences BNCT Treatment Product Portfolio Table 69. TAE Life Sciences Recent Development Table 70. Stella Pharma Company Information Table 71. Stella Pharma Business Overview Table 72. Stella Pharma BNCT Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Stella Pharma BNCT Treatment Product Portfolio Table 74. Stella Pharma Recent Development Table 75. Research Programs/Design for This Report Table 76. Authors List of This Report Table 77. Secondary Sources Table 78. Primary Sources List of Figures Figure 1. BNCT Treatment Product Image Figure 2. Global BNCT Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global BNCT Treatment Market Size (2021-2032) & (US$ Million) Figure 4. Global BNCT Treatment Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Equipment Image Figure 8. Solution Image Figure 9. Drug Image Figure 10. Global BNCT Treatment Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global BNCT Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global BNCT Treatment Sales Value Share by Type (2021-2032) Figure 13. Head and Neck Cancer Image Figure 14. Brain Tumor Image Figure 15. Others Image Figure 16. Global BNCT Treatment Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global BNCT Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global BNCT Treatment Sales Value Share by Application (2021-2032) Figure 19. Global BNCT Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global BNCT Treatment Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America BNCT Treatment Sales Value (2021-2032) & (US$ Million) Figure 22. North America BNCT Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe BNCT Treatment Sales Value (2021-2032) & (US$ Million) Figure 24. Europe BNCT Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific BNCT Treatment Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific BNCT Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America BNCT Treatment Sales Value (2021-2032) & (US$ Million) Figure 28. South America BNCT Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa BNCT Treatment Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa BNCT Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA BNCT Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA BNCT Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA BNCT Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada BNCT Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada BNCT Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada BNCT Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico BNCT Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico BNCT Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico BNCT Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany BNCT Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany BNCT Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany BNCT Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France BNCT Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France BNCT Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France BNCT Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. BNCT Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. BNCT Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. BNCT Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy BNCT Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy BNCT Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy BNCT Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain BNCT Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain BNCT Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain BNCT Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia BNCT Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia BNCT Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia BNCT Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands BNCT Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands BNCT Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands BNCT Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries BNCT Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries BNCT Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries BNCT Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China BNCT Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China BNCT Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China BNCT Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan BNCT Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan BNCT Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan BNCT Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea BNCT Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea BNCT Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea BNCT Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India BNCT Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India BNCT Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India BNCT Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia BNCT Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia BNCT Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia BNCT Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia BNCT Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia BNCT Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia BNCT Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil BNCT Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil BNCT Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil BNCT Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina BNCT Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina BNCT Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina BNCT Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile BNCT Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile BNCT Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile BNCT Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia BNCT Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia BNCT Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia BNCT Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru BNCT Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru BNCT Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru BNCT Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia BNCT Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia BNCT Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia BNCT Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel BNCT Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel BNCT Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel BNCT Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE BNCT Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE BNCT Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE BNCT Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey BNCT Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey BNCT Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey BNCT Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran BNCT Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran BNCT Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran BNCT Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt BNCT Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt BNCT Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt BNCT Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Equipment
  • Solution
  • Drug
Applications
  • Head and Neck Cancer
  • Brain Tumor
  • Others
Companies covered
  • Neutron Therapeutics
  • Sumitomo Heavy Industries
  • International Particle Therapy Inc (IPT)
  • RaySearch
  • Neuboron Medtech
  • TAE Life Sciences
  • Stella Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global BNCT Treatment Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global BNCT Treatment Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 BNCT Treatment Market Dynamics
  1. 2.1 BNCT Treatment Industry Trends
  2. 2.2 BNCT Treatment Industry Drivers
  3. 2.3 BNCT Treatment Industry Opportunities and Challenges
  4. 2.4 BNCT Treatment Industry Restraints
3 BNCT Treatment Market by Company
  1. 3.1 Global BNCT Treatment Company Revenue Ranking in 2025
  2. 3.2 Global BNCT Treatment Revenue by Company (2021-2026)
  3. 3.3 Global BNCT Treatment Company Ranking (2024-2026)
  4. 3.4 Global BNCT Treatment Company Manufacturing Base and Headquarters
  5. 3.5 Global BNCT Treatment Company Product Type and Application
  6. 3.6 Global BNCT Treatment Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global BNCT Treatment Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 BNCT Treatment Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 BNCT Treatment Market by Type
  1. 4.1 BNCT Treatment Type Introduction
  2. 4.1.1 Equipment
  3. 4.1.2 Solution
  4. 4.1.3 Drug
  5. 4.2 Global BNCT Treatment Sales Value by Type
  6. 4.2.1 Global BNCT Treatment Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global BNCT Treatment Sales Value by Type (2021-2032)
  8. 4.2.3 Global BNCT Treatment Sales Value Share by Type (2021-2032)
5 BNCT Treatment Market by Application
  1. 5.1 BNCT Treatment Application Introduction
  2. 5.1.1 Head and Neck Cancer
  3. 5.1.2 Brain Tumor
  4. 5.1.3 Others
  5. 5.2 Global BNCT Treatment Sales Value by Application
  6. 5.2.1 Global BNCT Treatment Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global BNCT Treatment Sales Value by Application (2021-2032)
  8. 5.2.3 Global BNCT Treatment Sales Value Share by Application (2021-2032)
6 BNCT Treatment Regional Value Analysis
  1. 6.1 Global BNCT Treatment Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global BNCT Treatment Sales Value by Region (2021-2032)
  3. 6.2.1 Global BNCT Treatment Sales Value by Region: 2021-2026
  4. 6.2.2 Global BNCT Treatment Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America BNCT Treatment Sales Value (2021-2032)
  7. 6.3.2 North America BNCT Treatment Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe BNCT Treatment Sales Value (2021-2032)
  10. 6.4.2 Europe BNCT Treatment Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific BNCT Treatment Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific BNCT Treatment Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America BNCT Treatment Sales Value (2021-2032)
  16. 6.6.2 South America BNCT Treatment Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa BNCT Treatment Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa BNCT Treatment Sales Value Share by Country, 2025 VS 2032
7 BNCT Treatment Country-level Value Analysis
  1. 7.1 Global BNCT Treatment Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global BNCT Treatment Sales Value by Country (2021-2032)
  3. 7.2.1 Global BNCT Treatment Sales Value by Country (2021-2026)
  4. 7.2.2 Global BNCT Treatment Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA BNCT Treatment Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA BNCT Treatment Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA BNCT Treatment Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada BNCT Treatment Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada BNCT Treatment Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada BNCT Treatment Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico BNCT Treatment Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico BNCT Treatment Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico BNCT Treatment Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany BNCT Treatment Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany BNCT Treatment Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany BNCT Treatment Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France BNCT Treatment Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France BNCT Treatment Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France BNCT Treatment Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. BNCT Treatment Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. BNCT Treatment Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. BNCT Treatment Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy BNCT Treatment Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy BNCT Treatment Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy BNCT Treatment Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain BNCT Treatment Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain BNCT Treatment Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain BNCT Treatment Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia BNCT Treatment Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia BNCT Treatment Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia BNCT Treatment Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands BNCT Treatment Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands BNCT Treatment Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands BNCT Treatment Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries BNCT Treatment Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries BNCT Treatment Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries BNCT Treatment Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China BNCT Treatment Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China BNCT Treatment Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China BNCT Treatment Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan BNCT Treatment Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan BNCT Treatment Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan BNCT Treatment Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea BNCT Treatment Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea BNCT Treatment Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea BNCT Treatment Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India BNCT Treatment Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India BNCT Treatment Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India BNCT Treatment Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia BNCT Treatment Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia BNCT Treatment Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia BNCT Treatment Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia BNCT Treatment Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia BNCT Treatment Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia BNCT Treatment Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil BNCT Treatment Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil BNCT Treatment Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil BNCT Treatment Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina BNCT Treatment Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina BNCT Treatment Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina BNCT Treatment Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile BNCT Treatment Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile BNCT Treatment Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile BNCT Treatment Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia BNCT Treatment Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia BNCT Treatment Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia BNCT Treatment Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru BNCT Treatment Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru BNCT Treatment Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru BNCT Treatment Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia BNCT Treatment Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia BNCT Treatment Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia BNCT Treatment Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel BNCT Treatment Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel BNCT Treatment Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel BNCT Treatment Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE BNCT Treatment Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE BNCT Treatment Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE BNCT Treatment Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey BNCT Treatment Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey BNCT Treatment Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey BNCT Treatment Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran BNCT Treatment Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran BNCT Treatment Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran BNCT Treatment Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt BNCT Treatment Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt BNCT Treatment Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt BNCT Treatment Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Neutron Therapeutics
  2. 8.1.1 Neutron Therapeutics Company Information
  3. 8.1.2 Neutron Therapeutics Business Overview
  4. 8.1.3 Neutron Therapeutics BNCT Treatment Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Neutron Therapeutics BNCT Treatment Product Portfolio
  6. 8.1.5 Neutron Therapeutics Recent Developments
  7. 8.2 Sumitomo Heavy Industries
  8. 8.2.1 Sumitomo Heavy Industries Company Information
  9. 8.2.2 Sumitomo Heavy Industries Business Overview
  10. 8.2.3 Sumitomo Heavy Industries BNCT Treatment Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sumitomo Heavy Industries BNCT Treatment Product Portfolio
  12. 8.2.5 Sumitomo Heavy Industries Recent Developments
  13. 8.3 International Particle Therapy Inc (IPT)
  14. 8.3.1 International Particle Therapy Inc (IPT) Company Information
  15. 8.3.2 International Particle Therapy Inc (IPT) Business Overview
  16. 8.3.3 International Particle Therapy Inc (IPT) BNCT Treatment Revenue and Gross Margin (2021-2026)
  17. 8.3.4 International Particle Therapy Inc (IPT) BNCT Treatment Product Portfolio
  18. 8.3.5 International Particle Therapy Inc (IPT) Recent Developments
  19. 8.4 RaySearch
  20. 8.4.1 RaySearch Company Information
  21. 8.4.2 RaySearch Business Overview
  22. 8.4.3 RaySearch BNCT Treatment Revenue and Gross Margin (2021-2026)
  23. 8.4.4 RaySearch BNCT Treatment Product Portfolio
  24. 8.4.5 RaySearch Recent Developments
  25. 8.5 Neuboron Medtech
  26. 8.5.1 Neuboron Medtech Company Information
  27. 8.5.2 Neuboron Medtech Business Overview
  28. 8.5.3 Neuboron Medtech BNCT Treatment Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Neuboron Medtech BNCT Treatment Product Portfolio
  30. 8.5.5 Neuboron Medtech Recent Developments
  31. 8.6 TAE Life Sciences
  32. 8.6.1 TAE Life Sciences Company Information
  33. 8.6.2 TAE Life Sciences Business Overview
  34. 8.6.3 TAE Life Sciences BNCT Treatment Revenue and Gross Margin (2021-2026)
  35. 8.6.4 TAE Life Sciences BNCT Treatment Product Portfolio
  36. 8.6.5 TAE Life Sciences Recent Developments
  37. 8.7 Stella Pharma
  38. 8.7.1 Stella Pharma Company Information
  39. 8.7.2 Stella Pharma Business Overview
  40. 8.7.3 Stella Pharma BNCT Treatment Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Stella Pharma BNCT Treatment Product Portfolio
  42. 8.7.5 Stella Pharma Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst